EUVIMEDEUVIMED entdecken
Crossref

Predictors of nodal upstaging in clinical N1 nonsmall cell lung cancer

Hidenao Kayawake iD, Jiro Okami, Yasushi Shintani, Hiroyuki Ito, Takashi Ohtsuka, Shinichi Toyooka, Takeshi Mori, Shun-Ichi Watanabe, Hisao Asamura, Masayuki Chida, Shunsuke Endo, Mitsutaka Kadokura und 5 weitere

Japanese Journal of Clinical Oncology · 2025

DOI: 10.1093/jjco/hyae161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Journal of Clinical Oncology, 2025. Verfasst von Hidenao Kayawake und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Kyoto University, 54, Shogoin-Kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Lymph Nodes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Surgical resection followed by adjuvant chemotherapy is currently the first choice for the treatment of clinical N1 (cN1) non-small cell lung cancer (NSCLC). However, diagnosing cN1 correctly can be difficult, even with current imaging diagnostic technologies. We aimed to analyze the diagnostic accuracy of preoperative nodal status and the predictive factors for nodal upstaging of cN1-NSCLC.

Methods

Patients receiving surgery for cN1-NSCLC in 2010 (n = 1040) were enrolled in the Japanese Joint Committee of Lung Cancer Registry Database. We investigated the diagnostic accuracy of cN1, predictive factors for nodal upstaging, and prognostic factors for overall survival (OS) and recurrence-free survival (RFS).

Results

The 5-year OS and RFS for all patients were 58.2% and 42.7%, respectively. The postoperative pathological nodal status included N0 (36.6%), N1 (39.7%), N2 (23.6%), and N3 (0.1%). In multivariate analysis, younger age (P = .005), no history of smoking (P = .006), and adenocarcinoma (P < .001) were significant predictive factors for nodal upstaging. Older age (P < .001) and higher clinical T (cT) factor (P < .001) were significant indicators for worse OS, while older age (P = .02), higher cT factor (P = .019), high carcinoembryonic antigen value (P = .002), and adenocarcinoma (P = .008) were significant indicators for worse RFS.

Conclusions

The diagnostic accuracy of cN1 in this study was ~40%. No history of smoking and adenocarcinoma were significant predictors for nodal upstaging. Although younger age was a significant predictor for nodal upstaging, it was a significant factor for better prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsLymph NodesHumansMaleFemaleMiddle AgedAgedNeoplasm StagingLymphatic MetastasisPrognosisAdultAged, 80 and overDisease-Free SurvivalAdenocarcinoma

Stichwörter der Autor:innen

clinical N1 nonsmall cell lung cancerdiagnostic accuracynodal upstagingpredictive factorprognostic factor

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Kyoto University, 54, Shogoin-Kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan.
  • Department of Thoracic Surgery, Kobe City Medical Center General Hospital, 2-1-1 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan.
  • Department of General Thoracic Surgery, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka 540-0008, Japan.
  • Department of General Thoracic Surgery, Graduate School of Medicine, Osaka University, 2-15 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Department of Thoracic Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi, Yokohama, Kanagawa 241-8515, Japan.
  • Division of Thoracic Surgery, Department of Surgery, Jikei University School of Medicine, Nishishinbashi 3-19-18, Minatoku, Tokyo 105-8471, Japan.

ORCID-Profile: Hidenao Kayawake

Zitieren

APA

Kayawake, H., Okami, J., Shintani, Y., Ito, H., Ohtsuka, T., Toyooka, S., Mori, T., Watanabe, S. I., Asamura, H., Chida, M., Endo, S., Kadokura, M., Nakanishi, R., Miyaoka, E., Yoshino, I., Date, H., & Japanese Joint Committee of Lung Cancer Registry (2025). Predictors of nodal upstaging in clinical N1 nonsmall cell lung cancer. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyae161

Vancouver

Kayawake H, Okami J, Shintani Y, Ito H, Ohtsuka T, Toyooka S, et al. Predictors of nodal upstaging in clinical N1 nonsmall cell lung cancer. Japanese Journal of Clinical Oncology. 2025. doi:10.1093/jjco/hyae161

BibTeX
@article{Kayawake2025,
  author = {Kayawake, Hidenao and Okami, Jiro and Shintani, Yasushi and Ito, Hiroyuki and Ohtsuka, Takashi and Toyooka, Shinichi and Mori, Takeshi and Watanabe, Shun-Ichi and Asamura, Hisao and Chida, Masayuki and Endo, Shunsuke and Kadokura, Mitsutaka and Nakanishi, Ryoichi and Miyaoka, Etsuo and Yoshino, Ichiro and Date, Hiroshi and Japanese Joint Committee of Lung Cancer Registry, Japanese Joint Committee of Lung Cancer Registry},
  title = {Predictors of nodal upstaging in clinical N1 nonsmall cell lung cancer},
  journal = {Japanese Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1093/jjco/hyae161}
}
Kostenlos starten →